Results 141 to 150 of about 84,633 (203)
Some of the next articles are maybe not open access.
Pharmacological Research, 2001
Emission tomography techniques and, in particular, positron emission tomography (PET) enable the in vivo study of several physiological and neurochemical variables in human subjects using methods originally developed for quantitative autoradiography. In particular, PET allows one to evaluate in human subjects: (a) the effect of specific neurochemical ...
MORESCO, ROSA MARIA +7 more
openaire +5 more sources
Emission tomography techniques and, in particular, positron emission tomography (PET) enable the in vivo study of several physiological and neurochemical variables in human subjects using methods originally developed for quantitative autoradiography. In particular, PET allows one to evaluate in human subjects: (a) the effect of specific neurochemical ...
MORESCO, ROSA MARIA +7 more
openaire +5 more sources
PET and PET/CT for Pancreatic Malignancies
PET Clinics, 2008FDG PET imaging is useful for preoperative diagnosis of pancreatic carcinoma in patients with suspected pancreatic cancer in whom CT fails to identify a discrete tumor mass or in whom FNAs are nondiagnostic. FDG PET imaging is useful for M staging and restaging by detecting CT occult metastatic disease, allowing noncurative resection to be avoided in ...
Dominique, Delbeke, William H, Martin
openaire +3 more sources
PET and PET/CT in Management of the Lymphomas
Radiologic Clinics of North America, 2006Within recent years, F-18 fluorodeoxyglucose (FDG) PET has become the most important nuclear medicine and radiology imaging modality in the management of lymphoma. FDG-PET detects more disease sites and involved organs than conventional staging procedures, including CT, and has a large influence on staging.
Donald A, Podoloff, Homer A, Macapinlac
openaire +3 more sources
2012
Molecular imaging with positron emission tomography (PET) using tumour-seeking radiopharmaceuticals has gained wide acceptance in oncology with many clinical applications. The hybrid imaging modality PET/CT allows assessing molecular as well as morphologic information at the same time.
Berud J, Krause +2 more
openaire +2 more sources
Molecular imaging with positron emission tomography (PET) using tumour-seeking radiopharmaceuticals has gained wide acceptance in oncology with many clinical applications. The hybrid imaging modality PET/CT allows assessing molecular as well as morphologic information at the same time.
Berud J, Krause +2 more
openaire +2 more sources
PET and PET/CT in Radiotherapy
2008Many aspects have to be considered in planning, applying, and following up radiotherapy procedures. This field poses a major challenge for diagnostic techniques. The first goal in the definition of multimodal oncological therapy concepts is to identify the patients who benefit from a definitive or adjuvant radiotherapy.
S, Könemann, M, Weckesser
openaire +2 more sources
Oral presentations, 2018
Objectives Concerns about unnecessary medical imaging have led to the development of guidelines for a variety of indications and modalities by radiology and specialty groups. This study evaluates the utility of four national imaging guidelines, which assess the value of positron emitting tomography/computed tomography (PET/CT).
Andreea Badea +2 more
openaire +1 more source
Objectives Concerns about unnecessary medical imaging have led to the development of guidelines for a variety of indications and modalities by radiology and specialty groups. This study evaluates the utility of four national imaging guidelines, which assess the value of positron emitting tomography/computed tomography (PET/CT).
Andreea Badea +2 more
openaire +1 more source
PET and PET/CT in cardiovascular disease
Annals of the New York Academy of Sciences, 2011The present review provides an overview of the role of cardiac positron emission tomography in the diagnosis and management of cardiovascular disease. It expands on the relative advantages and disadvantages over other imaging modalities as well as the available evidence supporting its value in the diagnosis and management of patients with coronary ...
Gaemperli, O, Kaufmann, P A
openaire +3 more sources